UnitedHealth Group Stock Drops 2.8% on Thursday

Analysts Forecast Growth Despite Decline in Share Price

Mar. 12, 2026 at 9:24pm

Got story updates? Submit your updates here. ›

UnitedHealth Group Incorporated (NYSE:UNH) saw its stock price drop 2.8% on Thursday, trading as low as $276.29 before closing at $277.29. The healthcare conglomerate saw an increase in trading volume of 4% compared to its average daily volume. Wall Street analysts have maintained a Moderate Buy rating on the stock, with a consensus target price of $372.13.

Why it matters

UnitedHealth Group is one of the largest healthcare companies in the United States, providing a wide range of health benefits and services. The stock's performance is closely watched as an indicator of the broader healthcare industry's health and investor sentiment.

The details

The drop in UnitedHealth Group's stock price on Thursday came despite analysts forecasting continued growth for the company. Several analysts have lowered their price targets for UNH in recent weeks, citing factors such as the ongoing COVID-19 pandemic and regulatory uncertainty. However, the majority of analysts still maintain a Buy rating on the stock.

  • UnitedHealth Group's stock closed at $285.25 on the previous trading day.
  • The stock traded as low as $276.29 and last traded at $277.29 on Thursday.

The players

UnitedHealth Group Incorporated

A diversified healthcare company that operates two primary business platforms: UnitedHealthcare and Optum. It provides a broad range of health benefits and healthcare services to individuals, employers, governmental entities, and other organizations.

Royal Bank Of Canada

A multinational financial services company that has lowered its target price for UnitedHealth Group from $408.00 to $361.00 and maintained an "outperform" rating on the stock.

Barclays

A multinational investment bank that has cut its price target for UnitedHealth Group from $391.00 to $327.00 and maintained an "overweight" rating on the stock.

Leerink Partners

An investment bank that has lowered its target price for UnitedHealth Group from $410.00 to $345.00 and maintained an "outperform" rating on the stock.

Morgan Stanley

A multinational investment bank that has reduced its price target for UnitedHealth Group from $411.00 to $409.00 and maintained an "overweight" rating on the stock.

Got photos? Submit your photos here. ›

What they’re saying

“We must not let individuals continue to damage private property in San Francisco.”

— Robert Jenkins, San Francisco resident (San Francisco Chronicle)

The takeaway

Despite the recent decline in UnitedHealth Group's stock price, Wall Street analysts remain largely bullish on the company's long-term prospects. The healthcare industry continues to face challenges, but UnitedHealth Group's diversified business model and strong market position suggest it is well-positioned to navigate the current environment.